1. Home
  2. ANTX vs EHI Comparison

ANTX vs EHI Comparison

Compare ANTX & EHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

N/A

Current Price

$5.98

Market Cap

172.9M

Sector

Health Care

ML Signal

N/A

Logo Western Asset Global High Income Fund Inc

EHI

Western Asset Global High Income Fund Inc

N/A

Current Price

$5.69

Market Cap

178.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ANTX
EHI
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
178.2M
IPO Year
2022
2003

Fundamental Metrics

Financial Performance
Metric
ANTX
EHI
Price
$5.98
$5.69
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
201.3K
183.7K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
32.56
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$5.68
52 Week High
$7.19
$6.70

Technical Indicators

Market Signals
Indicator
ANTX
EHI
Relative Strength Index (RSI) 59.20 34.71
Support Level $3.91 N/A
Resistance Level $7.05 $6.03
Average True Range (ATR) 0.32 0.05
MACD -0.01 -0.00
Stochastic Oscillator 75.63 9.86

Price Performance

Historical Comparison
ANTX
EHI

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

About EHI Western Asset Global High Income Fund Inc

Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income. The Fund's secondary investment objective is total return. It invests in an international portfolio of securities consisting of below-investment-grade fixed income securities, emerging market fixed income securities, and investment-grade fixed income securities. The Fund's investment portfolio comprises sovereign bonds, collateralized mortgage obligations, asset-backed securities, and fixed income securities from different corporate sectors, including financials, energy, consumer discretionary, and industrials, among others.

Share on Social Networks: